Bicara Therapeutics Inc Common Stock
Price & Volume
Stats
See more52W Range | $7.87-$30.99 |
Market Cap | $592.9M |
Shares Short | 10M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$3.48 |
News
See moreYahoo Finance • 3 months ago
Can Bicara (BCAX) Commercialize Ficera? Breakthrough 3-Year Data Faces Execution Risk in C-Suite Overhaul
Yahoo Finance • 3 months ago
Bicara Therapeutics Inc. Common Stock Q2 2026 Earnings Call Summary
Yahoo Finance • 3 months ago
Bicara Therapeutics Q2 Earnings Call Highlights
Yahoo Finance • 3 months ago
Bicara Therapeutics Announces Appointments of Jeremy Bender and Christy Oliger to Board of Directors
About
CEO | Dr. Claire Mazumdar Clemon M.B.A., Ph.D. |
CFO | Ms. Jennifer Larson |
Address | 116 Huntington Avenue, Boston, MA, United States, 02116 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 103 |